XML 21 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 3,686 $ 4,030
Receivable from the sale of IQOS System commercialization rights 0 1,721
Other 71 48
Inventories:    
Leaf tobacco 649 704
Other raw materials 204 186
Work in process 22 24
Finished product 340 266
Inventory, net 1,215 1,180
Income taxes 496 103
Other current assets 117 138
Total current assets 5,585 7,220
Property, plant and equipment, at cost:    
Land and land improvements 123 123
Buildings and building equipment 1,535 1,478
Machinery and equipment 2,684 2,578
Construction in progress 240 248
Property, plant and equipment, at cost 4,582 4,427
Less accumulated depreciation 2,930 2,819
Property, plant and equipment, net 1,652 1,608
Goodwill 6,791 5,177
Other intangible assets, net 13,686 12,384
Investments in equity securities ($0 million and $250 million at December 31, 2023 and 2022, respectively, measured at fair value) 10,011 9,600
Other assets 845 965
Total Assets 38,570 36,954 Close
Liabilities    
Current portion of long-term debt 1,121 1,556
Accounts payable 582 552
Accrued liabilities:    
Marketing 716 599
Settlement charges 2,563 2,925
Other 1,902 1,299
Deferred gain from the sale of IQOS System commercialization rights 2,700 0
Dividends payable 1,735 1,685
Total current liabilities 11,319 8,616
Long-term debt 25,112 25,124
Deferred income taxes 2,799 2,897
Accrued pension costs 130 133
Accrued postretirement health care costs 1,079 1,083
Deferred gain from the sale of IQOS System commercialization rights 0 2,700
Other liabilities 1,621 324
Total liabilities 42,060 40,877 Close
Contingencies (Note 17)
Stockholders’ Equity (Deficit)    
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935 935
Additional paid-in capital 5,906 5,887
Earnings reinvested in the business 31,094 29,792
Accumulated other comprehensive losses (2,673) (2,771)
Cost of repurchased stock (1,042,499,542 shares at December 31, 2023 and 1,020,427,195 shares at December 31, 2022) (38,802) (37,816)
Total stockholders’ equity (deficit) attributable to Altria (3,540) (3,973)
Noncontrolling interests 50 50
Total stockholders’ equity (deficit) (3,490) (3,923) Close
Total Liabilities and Stockholders’ Equity (Deficit) $ 38,570 $ 36,954